Botswana has signed an agreement with the global vaccine distribution scheme co-led by the World Health Organisation (WHO), giving it the option to buy coronavirus vaccines for 20% of its population. The country has registered a relatively low number of coronavirus cases, about 7,800 with 27 deaths, but its economy has been dealt a severe blow by the pandemic. Unlike many other African countries, Botswana does not qualify for subsidised vaccines under the Covax scheme because it is classified as an upper middle-income country, as are neighbours Namibia and SA. Botswana made an upfront payment to Covax this week and will have the option to secure roughly 940,800 vaccine doses under a two-dose regimen, Moses Keetile, deputy permanent secretary in the health ministry, said in an interview. Botswana went for the optional purchase model to allow it to opt out at a later stage if necessary, Keetile said, adding that it would ask development partners to contribute towards payments to the facility that are outstanding. Botswana could also consider bilateral deals with vaccine manufacturers if the need arises, but for now Covax is its preferred procurement route.
SOURCE: BUSINESS DAY LIVE
More Stories
At the Coalface of the Green Revolution, but Earning Crumbs
Harris Stresses that U.S. Interests in African Nations Extends beyond Competing with China
Lesotho’s Lawmakers Debated a Motion to Claim Huge Swathes of Territory from South Africa
New HRW Head Weighs in on the UK’s Plan to Deport Asylum Seekers to Kigali
South Africans Spent at least 9.5 Hours a Day Online in 2022
Togo Could Move the Needle on Tropical Diseases
Making It Easier for Everyday Africans to Take Advantage of Previously Restricted Asset Classes
Pirates Disrupt the Gulf of Guinea’s Usually Peaceful Waters
Chad’s Parliament has Approved a Bill to Nationalise Oil Assets
Unilever Nigeria Announces Exit of Home Care and Skin Cleansing Markets by End of the Year
Joshua Baraka is Ugandan Music’s Next Big Thing
Design for Human Rights